Charles H. Yoon

14.8k citations
45 papers · 1.9k indexed · h-index 18
Topics
Cancer Immunotherapy and Biomarkers (10 papers)Cutaneous Melanoma Detection and Management (9 papers)Melanoma and MAPK Pathways (8 papers)

In The Last Decade

Charles H. Yoon

43 papers receiving 1.9k citations

Peers

Charles H. Yoon
Comparison fields: 5 of 100
  • Molecular Biology 1.0k
  • Oncology 750
  • Immunology 686
  • Cancer Research 441
  • Surgery 123
Replace Sazuku Nisitani with:
Sazuku Nisitani Japan
Joseph L. Benci United States
David Satijn Netherlands
Jennifer Saam United States
Simon J. A. Buczacki United Kingdom
Austin G. Diamond United Kingdom
Irene Y. Cheung United States
Qingwei Zhu China
Juli P. Miller United States
Sahil Seth United States
Charles H. Yoon relative to Sazuku Nisitani Japan Sazuku Nisitani's profile →
Citations per field
00.5×10×15.8×
Sazuku Nisitani · 1×
Citations per year

Countries citing papers authored by Charles H. Yoon

Since Specialization
Citations

This map shows the geographic impact of Charles H. Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles H. Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles H. Yoon more than expected).

Fields of papers citing papers by Charles H. Yoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles H. Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles H. Yoon. The network helps show where Charles H. Yoon may publish in the future.

Co-authorship network of co-authors of Charles H. Yoon

This figure shows the co-authorship network connecting the top 25 collaborators of Charles H. Yoon. A scholar is included among the top collaborators of Charles H. Yoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles H. Yoon. Charles H. Yoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 2
3 6
4 0
5 13
6 79
7 6
8 39
9 89
10 3
11 14
12 80
13 42
14 337
15 2
16 62
17 17
18 3
19 6
20 24

About Charles H. Yoon

Charles H. Yoon is a scholar working on Aging, Oncology and Immunology, having authored 45 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Cutaneous Melanoma Detection and Management (9 papers) and Melanoma and MAPK Pathways (8 papers). The work is most often cited by research in Aging (78 citations), Immunology (686 citations) and Cancer Research (441 citations). Charles H. Yoon has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Paul W. Sternberg, Gregg D. Jongeward, Junho Lee, Jason W. Pyrdol, Yoshinaga Ito, Adrienne Luoma, Lucas Ferrari de Andrade, Kai W. Wucherpfennig, Guo‐Cheng Yuan and Jason S. Gold. Their work appears in journals such as Nature, Science and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026